Immunovia AB IMMNOV
Dividend Summary
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | – | – |
| Type | – | – |
| Per share | – | – |
| Declaration date | – | – |
| Ex-div date | – | – |
| Pay date | – | – |
Enter the number of Immunovia AB shares you hold and we'll calculate your dividend payments:
Sign up for Immunovia AB and we'll email you the dividend information when they declare.
Add Immunovia AB to receive free notifications when they declare their dividends.
Your account is set up to receive Immunovia AB notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| There are no Immunovia AB dividends. | ||||||||
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0öre | — |
| 2007 | 0.0öre | 0% |
| 2008 | 0.0öre | 0% |
| 2009 | 0.0öre | 0% |
| 2010 | 0.0öre | 0% |
| 2011 | 0.0öre | 0% |
| 2012 | 0.0öre | 0% |
| 2013 | 0.0öre | 0% |
| 2014 | 0.0öre | 0% |
| 2015 | 0.0öre | 0% |
| 2016 | 0.0öre | 0% |
| 2017 | 0.0öre | 0% |
| 2018 | 0.0öre | 0% |
| 2019 | 0.0öre | 0% |
| 2020 | 0.0öre | 0% |
| 2021 | 0.0öre | 0% |
| 2022 | 0.0öre | 0% |
| 2023 | 0.0öre | 0% |
| 2024 | 0.0öre | 0% |
| 2025 | Sign Up Required | |
Immunovia AB Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 15 July 2024
- 52 Week Low
- 0.0% on 15 July 2024
- Next Ex-Div-Date Countdown
- Sign Up Required
About Immunovia AB
Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- Sweden
- Share Price
- kr0.46 (yesterday's closing price)
- Shares in Issue
- 306 million
- Market Cap
- kr140mn
- 0
- Market Indices
- none
